cetylpyridinium chloride anhydrous has been researched along with Autosomal Chromosome Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoedemaekers, R | 1 |
Miller, SK | 1 |
Harris, CE | 1 |
Reinders, HS | 1 |
Budetti, PP; Starfield, B | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Autosomal Chromosome Disorders
Article | Year |
---|---|
Child health status and risk factors.
Topics: Adolescent; Adult; Child; Child Health Services; Child Nutritional Physiological Phenomena; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Culture; Ethnicity; Family Characteristics; Female; Fetal Death; Fetal Diseases; Health; Health Status; Health Surveys; Humans; Infant; Infant Mortality; Infant, Newborn; Male; Mass Screening; Morbidity; Mortality; Nutrition Surveys; Parents; Pregnancy; Risk; Social Behavior; Social Environment; Socioeconomic Factors; United States | 1985 |
4 other study(ies) available for cetylpyridinium chloride anhydrous and Autosomal Chromosome Disorders
Article | Year |
---|---|
Commercial predictive testing: the desirability of one overseeing body.
Topics: Advisory Committees; Chromosome Aberrations; Chromosome Disorders; Commerce; Decision Making; DNA Mutational Analysis; Europe; Freedom; Genetic Counseling; Genetic Diseases, Inborn; Genetic Services; Genetic Testing; Health; Humans; Laboratories; Politics; Reference Standards; Risk Assessment; Sequence Analysis, DNA; Social Control, Formal; United States | 2000 |
Ethics lobby forces rethink on growth hormones.
Topics: Child; Chromosome Aberrations; Chromosome Disorders; Control Groups; DNA, Recombinant; Ethical Review; Ethics; Ethics Committees; Ethics Committees, Research; Federal Government; Government; Government Regulation; Growth Disorders; Health; Hormones; Human Experimentation; Humans; Jurisprudence; National Institutes of Health (U.S.); Nontherapeutic Human Experimentation; Patient Care; Pharmaceutical Preparations; Placebos; Politics; Research Design; Risk; Risk Assessment; Social Control, Formal; Turner Syndrome; United States | 1992 |
Aborting abnormal fetuses: the parental perspective.
Topics: Abortion, Eugenic; Blood Transfusion; Child; Christianity; Chromosome Aberrations; Chromosome Disorders; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Decision Making; Disabled Persons; Ethical Analysis; Ethics; Fetus; Freedom; Genetic Diseases, Inborn; Health; Human Rights; Humans; Jehovah's Witnesses; Maternal-Fetal Relations; Moral Obligations; Parent-Child Relations; Parents; Personal Autonomy; Social Responsibility; Social Values; Treatment Refusal | 1991 |
A threat to disabled persons? On the genetics approach to developmental disabilities.
Topics: Abortion, Eugenic; Chromosome Aberrations; Chromosome Disorders; Disabled Persons; Disease; Down Syndrome; Ethics; Genetic Diseases, Inborn; Genetic Testing; Genetic Therapy; Health; Humans; Individuality; Muscular Dystrophy, Duchenne; Personhood; Persons with Mental Disabilities; Prejudice; Prenatal Diagnosis; Quality of Life; Self Concept; Stereotyping; Stress, Psychological; Value of Life | 1996 |